Published in J Virol on July 01, 2006
Genomic and bioinformatics analysis of human adenovirus type 37: new insights into corneal tropism. BMC Genomics (2008) 1.14
The adenovirus L4 33-kilodalton protein binds to intragenic sequences of the major late promoter required for late phase-specific stimulation of transcription. J Virol (2006) 1.05
Presence of the adenovirus IVa2 protein at a single vertex of the mature virion. J Virol (2008) 1.04
Ternary complex formation on the adenovirus packaging sequence by the IVa2 and L4 22-kilodalton proteins. J Virol (2007) 1.00
Adenovirus serotype 5 L4-22K and L4-33K proteins have distinct functions in regulating late gene expression. J Virol (2009) 0.99
Characterization of Empty adenovirus particles assembled in the absence of a functional adenovirus IVa2 protein. J Virol (2011) 0.96
Adenovirus late-phase infection is controlled by a novel L4 promoter. J Virol (2010) 0.93
The adenovirus L4-22K protein is multifunctional and is an integral component of crucial aspects of infection. J Virol (2012) 0.92
Formation of a multiple protein complex on the adenovirus packaging sequence by the IVa2 protein. J Virol (2007) 0.92
Efficient DNA packaging of bacteriophage PRD1 requires the unique vertex protein P6. J Virol (2007) 0.89
The adenovirus L4-33K protein regulates both late gene expression patterns and viral DNA packaging. J Virol (2013) 0.88
Adenovirus structural protein IIIa is involved in the serotype specificity of viral DNA packaging. J Virol (2011) 0.88
Structure, function and dynamics in adenovirus maturation. Viruses (2014) 0.88
Adenovirus IVa2 protein binds ATP. J Virol (2008) 0.86
The adenovirus L4-22K protein has distinct functions in the posttranscriptional regulation of gene expression and encapsidation of the viral genome. J Virol (2013) 0.86
Role for the L1-52/55K protein in the serotype specificity of adenovirus DNA packaging. J Virol (2008) 0.83
Processing of the l1 52/55k protein by the adenovirus protease: a new substrate and new insights into virion maturation. J Virol (2013) 0.83
Two cellular protein kinases, DNA-PK and PKA, phosphorylate the adenoviral L4-33K protein and have opposite effects on L1 alternative RNA splicing. PLoS One (2012) 0.80
The Human Adenovirus Type 5 L4 Promoter Is Negatively Regulated by TFII-I and L4-33K. J Virol (2015) 0.79
The human adenovirus 5 L4 promoter is activated by cellular stress response protein p53. J Virol (2013) 0.79
The adenovirus genome contributes to the structural stability of the virion. Viruses (2014) 0.79
Structures of Adenovirus Incomplete Particles Clarify Capsid Architecture and Show Maturation Changes of Packaging Protein L1 52/55k. J Virol (2015) 0.78
Identification and characterization of a DNA binding domain on the adenovirus IVa2 protein. Virology (2012) 0.78
Adenoviral L4 33K forms ring-like oligomers and stimulates ATPase activity of IVa2: implications in viral genome packaging. Front Microbiol (2015) 0.78
Regulation of human adenovirus alternative RNA splicing by the adenoviral L4-33K and L4-22K proteins. Int J Mol Sci (2015) 0.77
Conserved arginines of bovine adenovirus-3 33K protein are important for transportin-3 mediated transport and virus replication. PLoS One (2014) 0.77
Development of Potent Antiviral Drugs Inspired by Viral Hexameric DNA-Packaging Motors with Revolving Mechanism. J Virol (2016) 0.76
Components of Adenovirus Genome Packaging. Front Microbiol (2016) 0.75
Generation of cell lines to complement adenovirus vectors using recombination-mediated cassette exchange. BMC Biotechnol (2010) 0.75
Interaction between hexon and L4-100K determines virus rescue and growth of hexon-chimeric recombinant Ad5 vectors. Sci Rep (2016) 0.75
The adenovirus L4-22K protein regulates transcription and RNA splicing via a sequence-specific single-stranded RNA binding. Nucleic Acids Res (2016) 0.75
Adenoviral E4 34K protein interacts with virus packaging components and may serve as the putative portal. Sci Rep (2017) 0.75
Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol (1967) 106.91
Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol (1996) 5.71
Identification of a repeated sequence element required for efficient encapsidation of the adenovirus type 5 chromosome. J Virol (1987) 2.09
Adenovirus type 5 packaging domain is composed of a repeated element that is functionally redundant. J Virol (1990) 1.75
Adenovirus L1 52- and 55-kilodalton proteins are required for assembly of virions. J Virol (1989) 1.71
Encapsidation of viral DNA requires the adenovirus L1 52/55-kilodalton protein. J Virol (1998) 1.54
Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production. Hum Gene Ther (2000) 1.47
The product of the adenovirus intermediate gene IVa2 is a transcriptional activator of the major late promoter. J Virol (1994) 1.46
Properties of the adenovirus IVa2 gene product, an effector of late-phase-dependent activation of the major late promoter. J Virol (1996) 1.46
Control of adenovirus packaging. J Cell Biochem (2005) 1.43
Distinct roles of the Adenovirus E4 ORF3 protein in viral DNA replication and inhibition of genome concatenation. J Virol (2003) 1.42
Interaction of the adenovirus IVa2 protein with viral packaging sequences. J Virol (2000) 1.39
Replication-dependent activation of the adenovirus major late promoter is mediated by the increased binding of a transcription factor to sequences in the first intron. J Virol (1989) 1.34
Requirement of the adenovirus IVa2 protein for virus assembly. J Virol (2003) 1.33
Interaction of the adenovirus L1 52/55-kilodalton protein with the IVa2 gene product during infection. J Virol (1996) 1.28
Role for the adenovirus IVa2 protein in packaging of viral DNA. J Virol (2001) 1.28
Polypeptide structure and encoding location of the adenovirus serotype 2 late, nonstructural 33K protein. J Virol (1983) 1.28
Nuclear factor EF-1A binds to the adenovirus E1A core enhancer element and to other transcriptional control regions. Mol Cell Biol (1989) 1.26
Bipartite structure and functional independence of adenovirus type 5 packaging elements. J Virol (1997) 1.22
Functional interaction of the adenovirus IVa2 protein with adenovirus type 5 packaging sequences. J Virol (2005) 1.18
Cellular components interact with adenovirus type 5 minimal DNA packaging domains. J Virol (1998) 1.12
Identification of a novel downstream binding protein implicated in late-phase-specific activation of the adenovirus major late promotor. Nucleic Acids Res (1992) 1.11
Analysis of the interaction of the adenovirus L1 52/55-kilodalton and IVa2 proteins with the packaging sequence in vivo and in vitro. J Virol (2005) 1.08
Late nonstructural 100,000- and 33,000-dalton proteins of adenovirus type 2. I. Subcellular localization during the course of infection. J Virol (1981) 1.07
Truncation of the human adenovirus type 5 L4 33-kDa protein: evidence for an essential role of the carboxy-terminus in the viral infectious cycle. Virology (2001) 1.06
Different binding site requirements for binding and activation for the bipartite enhancer factor EF-1A. Nucleic Acids Res (1992) 1.03
The role of the L4 33K gene in adenovirus infection. Virology (1999) 0.99
The structure and function of the adenovirus major late promoter. Curr Top Microbiol Immunol (2003) 0.95
Role of bovine adenovirus-3 33K protein in viral replication. Virology (2004) 0.95
Late nonstructural 100,000- and 33,000-dalton proteins of adenovirus type 2. II. Immunological and protein chemical analysis. J Virol (1981) 0.94
Cooperative binding of EF-1A to the E1A enhancer region mediates synergistic effects on E1A transcription during adenovirus infection. J Virol (1991) 0.92
Regulation of adenovirus packaging. Curr Top Microbiol Immunol (2003) 0.91
Binding of CCAAT displacement protein CDP to adenovirus packaging sequences. J Virol (2003) 0.89
Adenovirus IVa2 protein plays an important role in transcription from the major late promoter in vivo. Virology (2004) 0.89
Minimal cis-acting elements required for adenovirus genome packaging. J Virol (2003) 0.88
Efficient generation and amplification of high-capacity adeno-associated virus/adenovirus hybrid vectors. J Virol (2002) 0.87
Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE. Science (2012) 2.22
Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer. Arch Otolaryngol Head Neck Surg (2009) 1.80
Adenovirus-facilitated nuclear translocation of adeno-associated virus type 2. J Virol (2002) 1.77
REST repression of neuronal genes requires components of the hSWI.SNF complex. J Biol Chem (2002) 1.73
Relocalization of the Mre11-Rad50-Nbs1 complex by the adenovirus E4 ORF3 protein is required for viral replication. J Virol (2005) 1.63
SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function. Science (2013) 1.57
Control of adenovirus packaging. J Cell Biochem (2005) 1.43
Distinct roles of the Adenovirus E4 ORF3 protein in viral DNA replication and inhibition of genome concatenation. J Virol (2003) 1.42
Orthogonal reactivity of metal and multimetal nanostructures for selective, stepwise, and spatially-controlled solid-state modification. ACS Nano (2009) 1.41
The PDZ binding motif of human papillomavirus type 16 E6 induces PTPN13 loss, which allows anchorage-independent growth and synergizes with ras for invasive growth. J Virol (2007) 1.40
Cellular proteins PML and Daxx mediate an innate antiviral defense antagonized by the adenovirus E4 ORF3 protein. J Virol (2008) 1.22
A failure to communicate: a qualitative exploration of care coordination between hospitalists and primary care providers around patient hospitalizations. J Gen Intern Med (2014) 1.22
Functional interaction of the adenovirus IVa2 protein with adenovirus type 5 packaging sequences. J Virol (2005) 1.18
The adenovirus E1A oncoprotein recruits the cellular TRRAP/GCN5 histone acetyltransferase complex. Oncogene (2003) 1.15
Propagation of infectious human papillomavirus type 16 by using an adenovirus and Cre/LoxP mechanism. Proc Natl Acad Sci U S A (2004) 1.15
Adenovirus E4 ORF3 protein inhibits the interferon-mediated antiviral response. J Virol (2007) 1.11
Adenovirus core protein VII protects the viral genome from a DNA damage response at early times after infection. J Virol (2011) 1.09
The adenovirus E4 ORF3 protein binds and reorganizes the TRIM family member transcriptional intermediary factor 1 alpha. J Virol (2007) 1.06
Preclinical models of HPV+ and HPV- HNSCC in mice: an immune clearance of HPV+ HNSCC. Head Neck (2009) 1.05
Temporal regulation of the Mre11-Rad50-Nbs1 complex during adenovirus infection. J Virol (2009) 1.04
The role of human papillomavirus 16 E6 in anchorage-independent and invasive growth of mouse tonsil epithelium. Arch Otolaryngol Head Neck Surg (2007) 1.00
Deletion of the PDZ motif of HPV16 E6 preventing immortalization and anchorage-independent growth in human tonsil epithelial cells. Head Neck (2008) 0.98
Function of conserved residues of human glutathione synthetase: implications for the ATP-grasp enzymes. J Biol Chem (2004) 0.97
Characterization of Empty adenovirus particles assembled in the absence of a functional adenovirus IVa2 protein. J Virol (2011) 0.96
The adenovirus L4-22K protein is multifunctional and is an integral component of crucial aspects of infection. J Virol (2012) 0.92
Catalytic loop motion in human glutathione synthetase: A molecular modeling approach. Biochem Biophys Res Commun (2006) 0.91
Xylosyl- and glucuronyltransferase functions of LARGE in α-dystroglycan modification are conserved in LARGE2. Glycobiology (2012) 0.91
Chemoselective attachment of small molecule effector functionality to human adenoviruses facilitates gene delivery to cancer cells. J Am Chem Soc (2010) 0.91
Binding of CCAAT displacement protein CDP to adenovirus packaging sequences. J Virol (2003) 0.89
Adenovirus structural protein IIIa is involved in the serotype specificity of viral DNA packaging. J Virol (2011) 0.88
The adenovirus L4-33K protein regulates both late gene expression patterns and viral DNA packaging. J Virol (2013) 0.88
Development of an adenoviral vaccine against E6 and E7 oncoproteins to prevent growth of human papillomavirus-positive cancer. Arch Otolaryngol Head Neck Surg (2008) 0.88
Minimal cis-acting elements required for adenovirus genome packaging. J Virol (2003) 0.88
Unnatural amino acid incorporation onto adenoviral (Ad) coat proteins facilitates chemoselective modification and retargeting of Ad type 5 vectors. J Virol (2011) 0.88
Altered bioavailability of platelet-derived factor VIII during thrombocytosis reverses phenotypic efficacy in haemophilic mice. Thromb Haemost (2008) 0.87
The adenovirus L4-22K protein has distinct functions in the posttranscriptional regulation of gene expression and encapsidation of the viral genome. J Virol (2013) 0.86
The role of the glycine triad in human glutathione synthetase. Biochem Biophys Res Commun (2010) 0.86
Adenovirus regulates sumoylation of Mre11-Rad50-Nbs1 components through a paralog-specific mechanism. J Virol (2012) 0.86
Adenovirus IVa2 protein binds ATP. J Virol (2008) 0.86
Biophysical and functional analyses suggest that adenovirus E4-ORF3 protein requires higher-order multimerization to function against promyelocytic leukemia protein nuclear bodies. J Biol Chem (2012) 0.85
Quantitative surface plasmon resonance imaging: a simple approach to automated angle scanning. Anal Chem (2008) 0.84
LEFTY, a member of the transforming growth factor-beta superfamily, inhibits uterine stromal cell differentiation: a novel autocrine role. Endocrinology (2010) 0.84
Adenovirus sequesters phosphorylated STAT1 at viral replication centers and inhibits STAT dephosphorylation. J Virol (2011) 0.83
Differential amplification of adenovirus vectors by flanking the packaging signal with attB/attP-PhiC31 sequences: implications for helper-dependent adenovirus production. Virology (2007) 0.83
Computationally designed adeno-associated virus (AAV) Rep 78 is efficiently maintained within an adenovirus vector. Proc Natl Acad Sci U S A (2011) 0.83
Adenovirus E4-ORF3-dependent relocalization of TIF1α and TIF1γ relies on access to the Coiled-Coil motif. Virology (2011) 0.83
The adenovirus E4 11 k protein binds and relocalizes the cytoplasmic P-body component Ddx6 to aggresomes. Virology (2011) 0.83
Role for the L1-52/55K protein in the serotype specificity of adenovirus DNA packaging. J Virol (2008) 0.83
The effect of proteasome inhibition on p53 degradation and proliferation in tonsil epithelial cells. Arch Otolaryngol Head Neck Surg (2008) 0.82
The adenovirus E4-6/7 protein directs nuclear localization of E2F-4 via an arginine-rich motif. J Virol (2005) 0.81
Induction of genes involved in cell cycle progression by interleukin-4. J Interferon Cytokine Res (2004) 0.79
Tet responsive and adenovirus based constructs for regulated in vivo expression of Lefty. Front Biosci (2006) 0.78
Aspartate 458 of human glutathione synthetase is important for cooperativity and active site structure. Biochem Biophys Res Commun (2011) 0.78
Valine 44 and valine 45 of human glutathione synthetase are key for subunit stability and negative cooperativity. Biochem Biophys Res Commun (2011) 0.78
A core viral protein binds host nucleosomes to sequester immune danger signals. Nature (2016) 0.78
Chromatin immunoprecipitation to study the binding of proteins to the adenovirus genome in vivo. Methods Mol Med (2007) 0.77
Scanning electron microscopy of nanoscale chemical patterns. ACS Nano (2007) 0.77
Altering the Ad5 packaging domain affects the maturation of the Ad particles. PLoS One (2011) 0.77
Physician-delivered malnutrition: why do patients receive nothing by mouth or a clear liquid diet in a university hospital setting? JPEN J Parenter Enteral Nutr (2011) 0.76
The use of chromatin immunoprecipitation (ChIP) to study the binding of viral proteins to the adenovirus genome in vivo. Methods Mol Biol (2014) 0.76
Expression of therapeutic levels of factor VIII in hemophilia A mice using a novel adeno/adeno-associated hybrid virus. Thromb Haemost (2004) 0.76
Effect of carbon dioxide on broth microdilution susceptibility testing of Brucella spp. J Clin Microbiol (2009) 0.75
The role of strong electrostatic interactions at the dimer interface of human glutathione synthetase. Protein J (2014) 0.75
Modeling gene expression in the mouse uterine horn by in vivo adenovirus-mediated gene delivery. Front Biosci (2005) 0.75
Glutathione synthetase promotes the reduction of arsenate via arsenolysis of glutathione. Biochimie (2012) 0.75